SGLT‐2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T‐Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes‐Related Hematological Malignancy
Crossref DOI link: https://doi.org/10.1002/jha2.70109
Published Online: 2025-09-08
Published Print: 2025-10
Update policy: https://doi.org/10.1002/crossmark_policy
Morichika, Kazuho
Tamaki, Keita
Fukushima, Takuya
Masuzaki, Hiroaki
Version of Record valid from 2025-09-08
Publication History
Received: 2025-05-05
Accepted: 2025-07-11
Published: 2025-09-08
